Axa S.A. Burning Rock Biotech LTD Transaction History

Axa S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$9.43 - $17.14 $254,610 - $462,780	-27,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$23.5 - $39.58 $23,500 - $39,580	-1,000 Reduced 3.57%	27,000 $727,000
Q4 2020 Feb 12, 2021	BUY	$22.55 - $30.87 $180,400 - $246,960	8,000 Added 40.0%	28,000 $647,000
Q3 2020 Nov 13, 2020	BUY	$19.07 - $29.61 $381,400 - $592,200	20,000 New	20,000 $502,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $684M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.